Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategy.
- DOI
- 10.1038/s41541-026-01483-z
- Published
- 2026 May 22
- Container
- NPJ vaccines
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41541-026-01483-z,
title = {Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategy.},
author = {Kim D and Lee JH and Lee J and Park JY and Shin Y and Kim SJ and Cheon B and Lee S and Cho E and Kim DR and McNamara RP and Yun CH and Siribie M and Aziz AB and Tadesse BT and Marks F and Jo SK and Jeon HJ and Rakotozandrindrainy R and Jani IV and Yang JS and Shim BS and Song M},
year = {2026},
journal = {NPJ vaccines},
doi = {10.1038/s41541-026-01483-z},
url = {https://doi.org/10.1038/s41541-026-01483-z}
}RIS
TY - JOUR TI - Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategy. AU - Kim D AU - Lee JH AU - Lee J AU - Park JY AU - Shin Y AU - Kim SJ AU - Cheon B AU - Lee S AU - Cho E AU - Kim DR AU - McNamara RP AU - Yun CH AU - Siribie M AU - Aziz AB AU - Tadesse BT AU - Marks F AU - Jo SK AU - Jeon HJ AU - Rakotozandrindrainy R AU - Jani IV AU - Yang JS AU - Shim BS AU - Song M PY - 2026 JO - NPJ vaccines DO - 10.1038/s41541-026-01483-z UR - https://doi.org/10.1038/s41541-026-01483-z ER -
APA
D, K., JH, L., J, L., JY, P., Y, S., SJ, K., B, C., S, L., E, C., DR, K., RP, M., CH, Y., M, S., AB, A., BT, T., F, M., SK, J., HJ, J., R, R., IV, J., JS, Y., BS, S., & M, S. (2026). Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategy.. NPJ vaccines. https://doi.org/10.1038/s41541-026-01483-z
Source records
- pubmed · retrieved 2026-09-27T08:38:37.977Z